Literature DB >> 16757458

Suicide in borderline personality disorder: a meta-analysis.

Maurizio Pompili1, Paolo Girardi, Amedeo Ruberto, Roberto Tatarelli.   

Abstract

Suicide is the major cause of death among patients with borderline personality disorder; however, the literature on completed suicides in such disorder is inconclusive, as suicide rates vary greatly among cohorts of patients. We searched MedLine, Excerpta Medica and PsycLit from 1980 to 2005 to identify papers dealing with suicide in borderline personality disorder. We also searched the World Health Statistics Annual to ascertain the suicide rate in the age groups for specific years and country. We selected eight studies comprising 1179 patients with a diagnosis of borderline personality disorder. Of these patients, 94 committed suicide. Results obtained for each study were processed together to calculate the mean figure for each year of suicides for 100,000 individuals suffering from borderline personality disorder. Our meta-analysis shows that suicide among patients with borderline personality disorder is more frequent when compared with the general population. All study analyses reported that patients with borderline personality disorder committed suicide more often than their counterparts in the general population. Suicide seems more alarming in the first phases of follow-up than during chronic phases of illness.

Entities:  

Mesh:

Year:  2005        PMID: 16757458     DOI: 10.1080/08039480500320025

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  33 in total

Review 1.  Suicidal risk and management in borderline personality disorder.

Authors:  Marianne Goodman; Tracey Roiff; Allison H Oakes; Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Shame as a prospective predictor of self-inflicted injury in borderline personality disorder: a multi-modal analysis.

Authors:  Milton Z Brown; Marsha M Linehan; Kathryn Anne Comtois; Angela Murray; Alexander L Chapman
Journal:  Behav Res Ther       Date:  2009-06-24

3.  Examination of pain threshold and neuropeptides in patients with acute suicide risk.

Authors:  Diane J Kim; Sarah J Blossom; Pedro L Delgado; Jessica M Carbajal; Ricardo Cáceda
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-07-19       Impact factor: 5.067

4.  National Trends in Suicide Attempts Among Adults in the United States.

Authors:  Mark Olfson; Carlos Blanco; Melanie Wall; Shang-Min Liu; Tulshi D Saha; Roger P Pickering; Bridget F Grant
Journal:  JAMA Psychiatry       Date:  2017-11-01       Impact factor: 21.596

Review 5.  Prescribing and borderline personality disorder.

Authors:  Andrew M Chanen; Katherine N Thompson
Journal:  Aust Prescr       Date:  2016-04-01

6.  The incremental validity of borderline personality disorder relative to major depressive disorder for suicidal ideation and deliberate self-harm in adolescents.

Authors:  Carla Sharp; Kelly L Green; Ilya Yaroslavsky; Amanda Venta; Mary C Zanarini; Jeremy Pettit
Journal:  J Pers Disord       Date:  2012-12

7.  The novel use of clozapine in an adolescent with borderline personality disorder.

Authors:  Sarah Elizabeth Argent; Simon Alastair Hill
Journal:  Ther Adv Psychopharmacol       Date:  2014-08

8.  Pain perception in female adolescents with borderline personality disorder.

Authors:  Petra Ludäscher; Clemens von Kalckreuth; Peter Parzer; Michael Kaess; Franz Resch; Martin Bohus; Christian Schmahl; Romuald Brunner
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-07-23       Impact factor: 4.785

9.  Suicide-associated comorbidity among US males and females: a multiple cause-of-death analysis.

Authors:  Ian R H Rockett; Shuhui Wang; Yinjuan Lian; Steven Stack
Journal:  Inj Prev       Date:  2007-10       Impact factor: 2.399

10.  Risks of all-cause and suicide mortality in mental disorders: a meta-review.

Authors:  Edward Chesney; Guy M Goodwin; Seena Fazel
Journal:  World Psychiatry       Date:  2014-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.